This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Navina closed a $55 million Series C funding round led by Goldman Sachs. The com...
A company that sought to make long-acting forms of commonly used drugs, with bac...
Eisai has slashed 2027 sales projections for its Biogen-partnered Alzheimer’s tr...
Mehmet Oz’s nomination to lead CMS will advance to the full Senate after clearin...
Following evidence showing that bacterial vaginosis affects both men and women, ...
Diagnostics company Revvity will sequence the DNA of newborns to help identify r...
Elon Musk's Department of Government Efficiency has reversed its termination of ...
What You Should Know: – The pharmaceutical research and development (R&D) secto...
What You Should Know: – Navina, a provider of AI-powered clinical intelligence ...
What You Should Know: – Xealth, the leader in digital health enablement for hea...
What You Should Know: – New research published in Clinical Diabetes, a peer-rev...
What You Should Know: – FuturHealth, a provider of personalized weight-loss sol...
What You Should Know: – Klarity Health, an innovator that empowers independent p...
There’s a common trap that businesses can fall into when it comes to technology ...
What You Should Know: – A new report from the Peterson Health Technology Instit...
Illumina on Tuesday added activist investor Keith Meister to its board and named...